Acasti Pharma

$0.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.045 (-5.88%) Today
+$0.01 (+1.39%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Acasti Pharma and other stocks, options, and ETFs commission-free!

About ACST

Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada. The listed name for ACST is Acasti Pharma, Inc. Class A Common Stock.

CEO
Janelle D'Alvise
Employees
—
Headquarters
Laval, Québec
Founded
2002
Market Cap
123.85M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
32.72M
High Today
$0.7793
Low Today
$0.70
Open Price
$0.7472
Volume
16.22M
52 Week High
$1.22
52 Week Low
$0.171

ACST Earnings

-$0.26
-$0.05
$0.16
$0.37
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Jun 29, Pre-Market

You May Also Like

SEPZ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure